期刊文献+

颈动脉血管成形和支架植入术治疗颅外颈动脉狭窄 被引量:6

Carotid angioplasty and stenting for extracranial carotid stenosis
下载PDF
导出
摘要 目的探讨颈动脉血管成形和支架植入术(CAS)治疗颅外颈动脉狭窄的安全性及治疗效果。方法回顾性分析199例颅外颈动脉狭窄病人的临床资料。病人均应用血管内支架成形术,其中应用脑保护装置108例,应用自膨胀支架197例。结果血管狭窄程度由支架植入前的(74.5±13.9)%降至支架植入后的(10.3±7.8)%(P〈0.01),围手术期无大卒中及死亡发生,出现小卒中3例(1.5%)。179例病人随访6~48个月,平均18.7个月,发生短暂性脑缺血发作(TIA)和脑卒中各2例,死亡2例。结论 CAS是颅外颈动脉狭窄的一种安全、有效的治疗手段。 Objective To study the safety and therapeutic outcome of carotid angioplasty and stenting(CAS) for extracranial carotid stenosis.Methods Clinical data of 199 patients with extracranial carotid stenosis were analyzed retrospectively,who were all treated by CAS.The cerebral protection device(CPD) was used in 108 patients and self-expandable stent in 197.Results The average stenosis rate was reduced from 74.5±13.9 % before operation to 10.3±7.8 % after operation(P 0.01).No death or major stroke occurred,and minor stroke occurred in 3 patients(1.5%) during the perioperative period.Follow-up was performed on 179 patients for 6 to 48 months with a mean time of 18.7 months.Transient ischemic attack occurred in 2 patients,stroke in 2 and death in 2.Conclusions CAS is a safe and effective strategy for extracranial carotid stenosis.
出处 《中国微侵袭神经外科杂志》 CAS 2012年第4期164-166,共3页 Chinese Journal of Minimally Invasive Neurosurgery
关键词 颈动脉狭窄 血管成形术 支架植入术 carotid stenosis angioplasty stent implantation
  • 相关文献

参考文献2

二级参考文献14

  • 1李慎茂,凌锋,缪中荣,朱凤水,吉训明,李斗,王默力,华扬.颈动脉狭窄血管内支架治疗并发症的临床分析[J].中国脑血管病杂志,2005,2(2):56-61. 被引量:128
  • 2凌锋,焦力群,代表国家"十五"医学攻关脑卒中规范化外科治疗技术推广应用研究课题组.颈动脉内膜剥脱术与支架成形术对颈动脉粥样硬化性狭窄治疗的初步研究[J].中国脑血管病杂志,2006,3(1):4-8. 被引量:60
  • 3缪中荣,凌锋.缺血性脑血管病血管内治疗的现状和问题[J].中华医学杂志,2006,86(3):145-146. 被引量:7
  • 4IBA T, KIDOKORO A, FUKUNAGA M, et al. Comparison of the protective effects of type Ⅲ phosphodiesterase (PDE3) inhibitor (cilostazol) and acetylsalicylic acid on intestinal microcirculation after ischemia reperfusion injury in mice [J]. Shock, 2006, 26(5): 522-526. 被引量:1
  • 5AHN Y, JEONG M H, JEONG J W, et al. Randomized comparison of cilostazol vs clopidogrel after drug-eluting stenting in diabetic patients-clilostazol for diabetic patients in drug-eluting stent (CIDES) trial [J]. Circ J, 2008, 72(1): 35-39. 被引量:1
  • 6LEE S W, PARK S W, KIM Y H, et al. Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLAREDIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy Atter Drug-Eluting Stent Implantation in Diabetic Patients) [J]. J Am Coll Cardiol, 2008, 51(12): 1181-1187. 被引量:1
  • 7PRATT C M. Analysis of the cilostazol safety database [J]. Am J Cardiol, 2001, 87(12A): 28D-33D. 被引量:1
  • 8DILLON W C, ECKERT G J, DILLON J C, et al. Incidence of thrombocytopenia following coronary stent placement using abciximab plus clopidogrel or ticlopidine [J]. Catheter Cardiovasc Interv, 2000, 50(4): 426-430. 被引量:1
  • 9KWON S U, CHO Y J, KOO J S, et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis [J]. Stroke, 2005, 36(4): 782-786. 被引量:1
  • 10KASTRUP A, GROSCHEL K, NAGELE T, et al. Effects of age and symptom status on silent ischemic lesions after carotid stenting with and without the use of distal filter devices [J]. Am J Neuroradiol, 2008, 29(3): 608-612. 被引量:1

共引文献16

同被引文献69

引证文献6

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部